"Pediatric cancer survivorship" trang 1 - tải miễn phí từ tailieunhanh
A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates

A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates
33    47    1
The landscape of coding RNA editing events in pediatric cancer

The landscape of coding RNA editing events in pediatric cancer
14    50    1
Delay in diagnosis and associated factors among children with cancer admitted at pediatric oncology ward, University of Gondar comprehensive specialized hospital, Ethiopia: A retrospective cross-sectional study

Delay in diagnosis and associated factors among children with cancer admitted at pediatric oncology ward, University of Gondar comprehensive specialized hospital, Ethiopia: A retrospective cross-sectional study
7    5    1
Predominance of girls with cancer in families with multiple childhood cancer cases

Predominance of girls with cancer in families with multiple childhood cancer cases
9    216    1
Using digital health to facilitate compliance with standardized pediatric cancer treatment guidelines in Tanzania: Protocol for an early-stage effectivenessimplementation hybrid study

Using digital health to facilitate compliance with standardized pediatric cancer treatment guidelines in Tanzania: Protocol for an early-stage effectivenessimplementation hybrid study
14    105    0
Development of the SPARK family member web pages to improve symptom management for pediatric patients receiving cancer treatments

Development of the SPARK family member web pages to improve symptom management for pediatric patients receiving cancer treatments
8    43    1
Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS

Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS
14    1    1
Feasibility of three times weekly symptom screening in pediatric cancer patients

Feasibility of three times weekly symptom screening in pediatric cancer patients
10    4    1
Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: A prospective cohort study (ARPEGE)

Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: A prospective cohort study (ARPEGE)
6    117    0
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: A randomized controlled trial with 5-year follow up

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: A randomized controlled trial with 5-year follow up
11    43    1
Development of a questionnaire to evaluate female fertility care in pediatric oncology, a TREL initiative

Development of a questionnaire to evaluate female fertility care in pediatric oncology, a TREL initiative
6    22    1
The potential of PARP as a therapeutic target across pediatric solid malignancies

The potential of PARP as a therapeutic target across pediatric solid malignancies
12    1    1
The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada

The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada
8    80    1
Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program

Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program
8    313    1
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy

Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
15    96    0
Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a noninterventional observation study

Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a noninterventional observation study
11    88    0
Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma

Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
15    94    0
Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
9    60    1
Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
11    48    1
PD-L1 assessment in pediatric rhabdomyosarcoma: A pilot study

PD-L1 assessment in pediatric rhabdomyosarcoma: A pilot study
9    77    1